|
|
Volumn 129, Issue 4, 2005, Pages 1348-1350
|
|
Does celecoxib use increase the risk of cardiovascular events?
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
IBUPROFEN;
LUMIRACOXIB;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARECOXIB;
PLACEBO;
ROFECOXIB;
VALDECOXIB;
ANALGESIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
CANCER PREVENTION;
CARCINOGENESIS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
COLORECTAL ADENOMA;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FATALITY;
DRUG MECHANISM;
DRUG SAFETY;
GASTROINTESTINAL SYMPTOM;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
NOTE;
POSTOPERATIVE PAIN;
PRIORITY JOURNAL;
RISK ASSESSMENT;
VENOUS THROMBOEMBOLISM;
|
|
EID: 26844545869
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1053/j.gastro.2005.08.029 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|